Skip to Main Content

Author Details

Camille Lobry
INSERM U1170, Universite Paris Saclay
2007
34
21
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36585521High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.Leukemia2023
35138899Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia.Sci Adv2022
35474100Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.Leukemia2022
35316324Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.Blood2022
35053311Super-Enhancers Dysregulations in Hematological Malignancies.Cells2022
33408769Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia.Theranostics2021
32826232The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.Cancer Discov2020
31028249Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages.Nat Commun2019
31662298Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.Cancer Discov2019
31453016Analysis of <i>TET2</i> mutations in paroxysmal nocturnal hemoglobinuria (PNH).Exp Hematol Oncol2019
29403038Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.Nat Cell Biol2018
28292442ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.Cancer Cell2017
28232365BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.Cancer Discov2017
27135740Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.Nat Med2016
27270779Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.Nat Med2016
27239026Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation.Cell Rep2016
25965569SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.Cancer Cell2015
26450952Restoring Ikaros's wings to solve a leukemia maze.Blood2015
26194287Erratum: TET1 is a tumor suppressor of hematopoietic malignancy.Nat Immunol2015
25867473TET1 is a tumor suppressor of hematopoietic malignancy.Nat Immunol2015
24608975Notch signaling: switching an oncogene to a tumor suppressor.Blood2014
25150294STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.Blood2014
23377202Distinct TCR signaling pathways drive proliferation and cytokine production in T cells.Nat Immunol2013
23791481In vivo mapping of notch pathway activity in normal and stress hematopoiesis.Cell Stem Cell2013
23359070Notch pathway activation targets AML-initiating cell homeostasis and differentiation.J Exp Med2013
22547652Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.J Exp Med2012
21030981PHF6 mutations in adult acute myeloid leukemia.Leukemia2011
22109558T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling.Proc Natl Acad Sci U S A2011
21948802Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.J Exp Med2011
21562564A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.Nature2011
21723200Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.Cancer Cell2011
17213322Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.Proc Natl Acad Sci U S A2007
17433222[New Bcl10 regulation mechanisms: a step in the comprehension of what has occurred in MALT lymphomas?].Med Sci (Paris)2007
17937895[Regulation of NF-kappaB pathway in T lymphocytes].Med Sci (Paris)2007
  • 1 - 34 of 34

Recommended Authors

The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 4
Boston Children's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 0
Universite de Toulouse, Inserm, Universite Toulouse III-Paul Sabatier
Career Start Year 2005
Number of shared co-authors 4
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
National Center for Advancing Translational Sciences
Career Start Year 2004
Number of shared co-authors 2
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2004
Number of shared co-authors 3
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 1
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 3
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 1
Institute for Cancer Genetics, Columbia University
Career Start Year 1999
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 4
St Jude Children's Research Hospital
Career Start Year 1996
Number of shared co-authors 13
Kyoto University
Career Start Year 1993
Number of shared co-authors 10
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 1
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 3
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 3
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 2
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 2
Institut de recherches cliniques de Montreal
Career Start Year 1985
Number of shared co-authors 0
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 2
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 5
National Cancer Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 5
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 2
Harvard Stem Cell Institute, Harvard Medical School
Career Start Year 1975
Number of shared co-authors 9
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 10

Collaborators

INSERM U7, Universite Paris-Saclay
Co-authored papers 4
Boston Children's Hospital
Co-authored papers 3
Fred Hutchinson Cancer Research Center, University of Washington
Co-authored papers 3
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 3
Co-authored papers 3
Universite de Paris, INSERM, CNRS
Co-authored papers 3
NYU Robert I. Grossman School of Medicine
Co-authored papers 2
INSERM U1170, Gustave Roussy Cancer Center and Universite Paris Saclay
Co-authored papers 2
The Broad Institute of MIT and Harvard
Co-authored papers 2
University of Wisconsin School of Medicine and Public Health
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Saint-Louis Hospital
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers 1
Universite Cote d'Azur, INSERM U5
Co-authored papers 1
The University of Chicago
Co-authored papers 1
Shanghai General Hospital, Shanghai Jiaotong University
Co-authored papers 1
INSERM, France Villejuif Universite Paris-Saclay
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Universite de Paris, Inserm CIC 1427
Co-authored papers 1
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers 1
Fred Hutchinson Cancer Research Centre
Co-authored papers 1